Download PDF
Geburtshilfe Frauenheilkd 2016; 76(01): 17-19
DOI: 10.1055/s-0035-1552482
Aktuell diskutiert
Georg Thieme Verlag KG Stuttgart · New York

Onkologie – Klimakterisches Syndrom nach Brustkrebserkrankung

Christian Dadak
Further Information

Publication History

Publication Date:
03 February 2016 (online)

Also available at
    Permissions and Reprints

Nach Brustkrebserkrankungen kann es aufgrund der Chemotherapie und auch durch chirurgische Interventionen bei beidseitiger Ovarektomie sowie durch Antihormontherapie mit Tamoxifen als auch mit Aromatasehemmern zum artifiziellen Menopausenstatus kommen. Der artifizielle, plötzliche Menopausenstatus wird viel unangenehmer erlebt als der natürliche, gleitende Übergang in das Klimakterium [1].

 

  • Literatur

  • 1 Nelson HD. Menopause. Lancet 2008; 371: 760-70
    CrossrefPubMedGoogle Scholar
  • 2 Lester J, Pahouja G, Andersen B et al. Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med 2015; 5: 50-66
    CrossrefPubMedGoogle Scholar
  • 3 Joffe H, Guthrie KA, LaCroix AZ et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med 2014; 174: 1058-1066
    CrossrefPubMedGoogle Scholar
  • 4 Butt DA, Lock M, Lewis JE et al. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008; 15: 310-318
    CrossrefPubMedGoogle Scholar
  • 5 Kuiper GG, Lemmen JC, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263
    CrossrefPubMedGoogle Scholar
  • 6 Boucher BA, Cotterchio M, Anderson LN et al. Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk. Int J Cancer 2013; 132: 1439-1450
    CrossrefPubMedGoogle Scholar
  • 7 Tempfer CB, Hefler LA, Huber JC. Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med 2009; 122: 939-946
    CrossrefPubMedGoogle Scholar
  • 8 Druckmann RA. Non-hormonal treatment of vasomotor symptoms in female patients with and after breast carcinoma. Maturitas 2015; 81: 160
    PubMedGoogle Scholar
  • 9 Druckmann R, Goldstein SR, Espié M. Führt Relizen®/Femalen®, eine nicht-hormonelle Behandlung für vasomotorische Symptome, zu einer Hemmung des CYP2D6-Enzymsystems?. Washington DC: North American Menopause Society; 2014
    Google Scholar
  • 10 Grindler NM, Santoro NF. Menopause and exercise. Menopause 2015; Sep 21 [Epub ahead of print]
    PubMedGoogle Scholar
  • 11 Huang AJ, Phillips S, Schembri M et al. Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial. Obstet Gynecol 2015; 125: 1130-1138
    CrossrefPubMedGoogle Scholar
  • 12 Daley A, Stokes-Lampard H, Thomas A et al. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2014; DOI: 10.1002/14651858.CD006108.pub4.
    PubMedGoogle Scholar
  • 13 Hoeg A, Gogakos A, Murphy E et al. Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2012; 97: 4061-4070
    CrossrefPubMedGoogle Scholar
  • 14 Pfeiler G, Glatz C, Königsberg R et al. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients. Climacteric 2011; 14: 339-344
    CrossrefPubMedGoogle Scholar
  • 15 Mueck A. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe: Anwendungsempfehlung zur Hormonsubstitution in Klimakterium und Postmenopause. Frauenarzt 2015; 56: 657-660
    PubMedGoogle Scholar
  • 16 Ekin M, Yaşar L, Savan K et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet 2011; 283: 539-543
    CrossrefPubMedGoogle Scholar
  • 17 Tea MKM, Priemer V, Kubista E. Wirksamkeit und Sicherheit von Hyaluron-Säure-Zäpfchen (Cikatridina®) bei der Behandlung hormon- oder chemotherapie-induzierter vaginaler Atrophie bei Mammakarzinompatientinnen. J Fertil Reprod 2006; 16: 17-19
    PubMedGoogle Scholar
  • 18 Chen J, Geng L, Song X et al. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-croup clinical trial. J Sex Med 2013; 10: 1575-1584
    CrossrefPubMedGoogle Scholar
  • 19 Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996; 23: 259-263
    CrossrefPubMedGoogle Scholar
  • 20 Petricevic L, Unger FM, Viernstein H et al. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gyn 2008; 141: 54-57
    PubMedGoogle Scholar